Funds and ETFs Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Real-time Estimate Cboe Europe 09:46:11 2024-05-27 EDT 5-day change 1st Jan Change
618.5 DKK +5.46% Intraday chart for Zealand Pharma A/S -1.04% +65.06%
Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2022, the Group had a portfolio of 7 products in clinical development (including 2 in phase III, 3 in phase II and 2 in phase I), and 4 products in preclinical development.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
586.5 DKK
Average target price
785.6 DKK
Spread / Average Target
+33.94%
Consensus
  1. Stock Market
  2. Equities
  3. ZEAL Stock
  4. Funds and ETFs Zealand Pharma A/S